Organigram, a licensed producer of cannabis, agreed to invest €14m in Sanity Group, a Berlin-based cannabis company. "Our investment in Sanity Group establishes a significant European footprint for us. Organigram benefits from Sanity’s expertise and insights in the German (and in the future) other European cannabis markets. This has the potential to provide a pathway for us to launch our own brands and industry-leading IP through Sanity’s extensive distribution network. This relationship also bolsters our European revenue generation through a significantly expanded commercial agreement," Beena Goldenberg, Organigram CEO.